CRBU - Caribou Biosciences, Inc.

QQQ $ 446.25 $ -12.35 (-2.68 %)

DIA $ 404.28 $ -3.99 (-0.98 %)

SPY $ 539.90 $ -9.25 (-1.68 %)

TLT $ 99.49 $ -0.01 (-0.01 %)

GLD $ 230.65 $ -1.72 (-0.74 %)

Previous Close

$ 1.72

Open

Bid

$ 1.72 x 1,933

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 1.50 - $ 8.33

Volume

2,625,882

Average Volume

Market Cap

155.42M

Beta (5Y Monthly)

$ 1.85

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-06-2024	06-30-2024	10-Q
2	05-07-2024	03-31-2024	10-Q
3	03-11-2024	12-31-2023	10-K
4	11-07-2023	09-30-2023	10-Q
5	08-08-2023	06-30-2023	10-Q
6	05-09-2023	03-31-2023	10-Q
7	03-09-2023	12-31-2022	10-K
8	11-08-2022	09-30-2022	10-Q
9	08-09-2022	06-30-2022	10-Q
10	05-09-2022	03-31-2022	10-Q
11	03-21-2022	12-31-2021	10-K
12	11-09-2021	09-30-2021	10-Q
13	09-02-2021	06-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Caribou Biosciences CFO Jason O'Byrne Info...
09/03/2024 20:04:26

- Reuters

Expert Ratings For Caribou Biosciences
09/03/2024 17:00:26

HC Wainwright & Co. Reiterates Buy on Cari...
09/03/2024 15:10:03

HC Wainwright & Co. analyst Robert Burns reiterates Caribou Biosciences (NASDAQ:CRBU) with a Buy and maintains $9 price ...

$caribou-biosciences-announces-the-fda-has-granted-fast-track-designations-to-cb-010-in-refractory-sle-and-to-cb-012-in-relapsed-or-refractory-aml$

Caribou Biosciences Announces The FDA Has ...
09/03/2024 12:25:41

-- Fast Track designation is designed to expedite clinical development and regulatory review timelines -- -- Additional FDA des...

Caribou Biosciences Stock: A Deep Dive Int...
08/14/2024 14:00:14

HC Wainwright & Co. Reiterates Buy on Cari...
08/14/2024 11:00:52

HC Wainwright & Co. analyst Robert Burns reiterates Caribou Biosciences (NASDAQ:CRBU) with a Buy and maintains $9 price ...

RBC Capital Reiterates Outperform on Carib...
08/07/2024 15:53:00

RBC Capital analyst Luca Issi reiterates Caribou Biosciences (NASDAQ:CRBU) with a Outperform and maintains $14 price target.

Caribou Biosciences Q2 EPS $(0.42) Beats $...
08/06/2024 21:12:17

Caribou Biosciences (NASDAQ:CRBU) reported quarterly losses of $(0.42) per share which beat the analyst consensus estimate of $...

Evaluating Caribou Biosciences: Insights F...
07/17/2024 12:00:19

HC Wainwright & Co. Reiterates Buy on Cari...
07/17/2024 10:12:53

HC Wainwright & Co. analyst Robert Burns reiterates Caribou Biosciences (NASDAQ:CRBU) with a Buy and maintains $9 price ...

Caribou Biosciences Discontinues Preclinic...
07/16/2024 20:18:16

- Reuters

Cracking The Code: Understanding Analyst R...
06/04/2024 13:00:30

HC Wainwright & Co. Maintains Buy on Carib...
06/04/2024 10:13:37

HC Wainwright & Co. analyst Robert Burns maintains Caribou Biosciences (NASDAQ:CRBU) with a Buy and lowers the price tar...

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
06/03/2024 16:31:06

Caribou Biosciences Announced Clinical Da...
06/02/2024 23:59:39

attention-biotech-investors---stocks-to-watch-from-rbc-global-healthcare-conference

Attention Biotech Investors - Stocks To Wa...
05/16/2024 18:21:31

RBC's Chris McCarthy discusses biotech investor sentiment at the RBC Global Healthcare Conference. Focused on upcoming bina...

Expert Ratings For Caribou Biosciences
05/16/2024 18:01:25

Truist Securities Maintains Buy on Caribou...
05/16/2024 17:11:51

Truist Securities analyst Asthika Goonewardene maintains Caribou Biosciences (NASDAQ:CRBU) with a Buy and maintains $19 pric...

HC Wainwright & Co. Reiterates Buy on Cari...
05/13/2024 17:44:44

HC Wainwright & Co. analyst Robert Burns reiterates Caribou Biosciences (NASDAQ:CRBU) with a Buy and maintains $24 price...

Caribou Biosciences Q1 EPS $(0.46) Misses ...
05/07/2024 21:16:31

Caribou Biosciences (NASDAQ:CRBU) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of...